- Time
- Topic
- Speaker
- Moderator
- Shin-ichi Muramatsu
- MD, PhD
-
Visiting Professor, Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University
E-mail：muramats@jichi.ac.jp
Executive Summary：
He is an honorary professor at Jichi Medical University (JMU) in Japan. He received his M.D. and Ph.D. from JMU. He completed his neurology residency at Gunma University and JMU. He was a visiting associate at the National Institutes of Health in the USA from 1995 to 1997. His research interest is gene and cell therapies for neurological diseases. Using adeno-associated virus (AAV) vectors, his group has been developing gene therapies for Parkinson’s disease (PD), Alzheimer’s disease, amyotrophic lateral sclerosis, and spinocerebellar ataxia. As a principal investigator, he conducted a clinical trial of gene therapy for PD, in which AAV vectors expressing dopamine-synthesizing enzymes were infused into the putamen. Dr. Muramatsu’s expertise has contributed to a clinical trial of gene therapy for AADC deficiency in Taiwan and Japan. He is one of the founding members of Gene Therapy Research Institution Co., Ltd, which is currently ONODERA GT Pharma, Inc.
Lecture Abstract：
SELECT * FROM faculty where Se3_1_02 ='The Future of Parkinson’s Treatment: Global Perspectives on Gene Therapy ' and fa_id=10==
